Skip to main content

F-star Therapeutics, Inc.

FSTXDelisted Mar 9, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001566373

F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.

Holders of 5% or more of FSTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of F-star Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of F-star Therapeutics, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

20 Schedule 13D and 13G filings on F-star Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on FSTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 17, 2023Beryl Capital Management LLC13GOld format–New–SEC
Feb 14, 2023Ridgeback Capital Investments L.P.13G/AOld format–––SEC
Feb 14, 2023Ridgeback Capital Investments L.P.13G/AOld format–––SEC
Feb 15, 2022Rock Springs Capital Management LP13G/AOld format–––SEC
Feb 14, 2022Atlas Venture Opportunity Fund I, L.P.13G/AOld format–––SEC
Feb 14, 2022Boxer Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Ridgeback Capital Investments L.P.13G/AOld format–––SEC
Feb 14, 2022Point72 Asset Management, L.P.13G/AOld format–––SEC
Feb 10, 20224:50 PM ETGSK plc13G/AOld format–––SEC
Feb 8, 2022Merck KGaA13G/AOld format–––SEC
May 26, 2021Cooperatieve AESCAP Venture I U.A.13D/AOld format–––SEC
May 18, 2021Point72 Asset Management, L.P.13GOld format–New–SEC
May 17, 2021Boxer Capital, LLC13GOld format–New–SEC
May 17, 2021Rock Springs Capital Management LP13GOld format–New–SEC
Apr 9, 2021Ridgeback Capital Investments L.P.13G/AOld format–––SEC
Feb 16, 2021Ridgeback Capital Investments L.P.13G/AOld format–––SEC
Feb 16, 2021Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 3, 2021Atlas Venture Fund VII L P13GOld format–New–SEC
Feb 3, 2021Atlas Venture Opportunity Fund I, L.P.13GOld format–New–SEC
Feb 1, 2021Merck KGaA13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell F-star Therapeutics, Inc. shares.

No Form 144 notices for F-star Therapeutics, Inc. are on file.